<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02392078</url>
  </required_header>
  <id_info>
    <org_study_id>LAANTERN</org_study_id>
    <nct_id>NCT02392078</nct_id>
  </id_info>
  <brief_title>Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System</brief_title>
  <acronym>LAANTERN</acronym>
  <official_title>Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monteris Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Monteris Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is
      being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS
      has been used in over 1300 procedures conducted at approximately 56 leading institutions
      across United States. This is a prospective, multi-center registry that will include data
      collection up to 12 months to evaluate procedural success, local control failure rate, and
      QoL in up to 1,000 patients and up to 50 sites. Currently, the study has 162 subjects
      enrolled from 14 active sites
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>up to 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Local control Failure Rate</measure>
    <time_frame>up to 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>up to 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety (Reportable adverse events)</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metastatic Brain Tumor</condition>
  <condition>Primary Brain Tumor</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NeuroBlate System</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who preferred management for soft tissue through interstitial irradiation or
        thermal therapy by the NeuroBlate® System, in the opinion of the treating physician
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient or legally authorized representative provides written authorization and/or
             consent per institution and geographical requirements

          2. Patient who is to undergo thermal therapy by the NeuroBlate® System for treatment of
             their neurological disorder

        Exclusion Criteria:

          1. Patient who is, or is expected to be inaccessible for follow-up

          2. Patient meets any exclusion criteria required by local law (e.g. age)

          3. Other concurrent medical or other condition (chronic or acute in nature) that in the
             opinion of the investigator may prevent participation or otherwise render patient
             ineligibility for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Leuthardt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nissa Mollema</last_name>
    <phone>763-253-4710</phone>
    <email>nmollema@monteris.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurelius Butler</last_name>
    <phone>(763) 762-2715</phone>
    <phone_ext>2715</phone_ext>
    <email>abutler@monteris.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Barrow Neurological Institute at Dignity Health St. Joseph's Hospital &amp; Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odilette Trevizo, RN, CNRN</last_name>
      <phone>602-406-1463</phone>
      <email>Odilette.Trevizo@DignityHealth.org</email>
    </contact>
    <investigator>
      <last_name>Kris Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lara Rose</last_name>
      <phone>858-822-6575</phone>
      <email>ljrose@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>David Piccioni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Hess</last_name>
      <phone>203-737-6259</phone>
      <email>judith.hess@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Veronica Chiang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriella Anderson</last_name>
      <phone>407-303-3214</phone>
      <email>Gabriella.Anderson@flhosp.org</email>
    </contact>
    <investigator>
      <last_name>Melvin Field, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Richardson</last_name>
      <phone>913-574-0412</phone>
      <email>lrichardson5@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Patrick Landazuri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Williford</last_name>
      <phone>502-852-7402</phone>
      <email>aowill01@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Neimat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanine Portell</last_name>
      <phone>314-362-2940</phone>
      <email>jportell@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Albert Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ichan School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Adams</last_name>
      <email>Ryan.Adams@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Constantino Hadjipanayis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alyson Hignight</last_name>
      <phone>212-746-1788</phone>
      <email>alh2031@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Rohan Ramakrishna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Huckins</last_name>
      <phone>315-464-8477</phone>
      <email>huckinss@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Zulma Tovar-Spinoza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexia Bwensa</last_name>
      <phone>919-681-5484</phone>
      <email>alexia.bwensa@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Fecci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Jenkins</last_name>
      <phone>336-716-3842</phone>
      <email>wejenkin@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Tatter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Fahrion</last_name>
      <phone>216-983-5169</phone>
      <email>jennifer.fahrion@uhhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Andrew Sloan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Allison</last_name>
      <phone>216-444-6459</phone>
      <email>ALLISOT@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Alireza Mohammadi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Dougherty</last_name>
      <phone>215-955-7962</phone>
      <email>Jaime.Dougherty@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Kevin Judy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MD Anderson</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Jacobs</last_name>
      <phone>713-745-3246</phone>
      <email>cjacobs@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Ganesh Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ru Chen Guo</last_name>
      <phone>604-875-4111</phone>
      <phone_ext>61505</phone_ext>
      <email>rchen.guo@ubc.ca</email>
    </contact>
    <investigator>
      <last_name>Brian Toyota, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2015</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Procedural Success</keyword>
  <keyword>Progression</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

